UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended	6 Months Ended
Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue:
Revenue	$ 0	$ 0	$ 500,000	$ 0
Operating expenses:
Research and development expense	0	0	0	1,423,000
General and administrative expense	1,235,000	5,642,000	2,571,000	8,758,000
Total operating expenses	1,235,000	5,642,000	2,571,000	10,181,000
Operating loss	(1,235,000)	(5,642,000)	(2,071,000)	(10,181,000)
Other (expense) income, net:
Dividend income	1,000	15,000	5,000	32,000
Interest income	3,000	13,000	6,000	24,000
Interest expense	(6,000)	0	(6,000)	0
Other income	637,000		637,000
Other expense		(150,000)		(46,000)
Total other (expense) income, net	635,000	(122,000)	642,000	10,000
Net loss before provision for income taxes	(600,000)	(5,764,000)	(1,429,000)	(10,171,000)
Provision for income taxes	0	0	0	0
Net loss	$ (600,000)	$ (5,764,000)	$ (1,429,000)	$ (10,171,000)
Basic loss per common share (in dollars per share)	$ (0.07)	$ (0.68)	$ (0.17)	$ (1.38)
Diluted loss per common share (in dollars per share)	$ (0.07)	$ (0.68)	$ (0.17)	$ (1.38)
Weighted-average basic common shares outstanding (in shares)	8,651,078	8,432,394	8,650,878	7,366,594
Weighted-average diluted common shares outstanding (in shares)	8,651,078	8,432,394	8,650,878	7,366,594

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.